Form 4: Sanderling Venture Partners Increase Stake in CalciMedica, Inc.

Sanderling Venture Partners and related entities report acquiring additional shares of CalciMedica, Inc. common stock at $3.75 per share.

Summary

• Sanderling Venture Partners VI Co Investment Fund LP and related entities filed a Form 4 detailing changes in their beneficial ownership of CalciMedica, Inc. common stock.
• On November 1, 2024, they acquired 86,867 shares at a price of $3.75 per share.
• Additionally, 877 shares were acquired at the same price.
• Following these transactions, the reporting persons' beneficial ownership includes direct and indirect holdings through various entities such as Sanderling Ventures Management VI, Sanderling Venture Partners VI, LP, and others.
• The total indirect holdings amount to a significant number of shares distributed across these entities.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a routine filing indicating insider transactions. The increased stake could be seen as a positive signal, but without further context, it's difficult to gauge the overall impact.

Positives

• The acquisition of additional shares by Sanderling Venture Partners could be interpreted as a sign of confidence in CalciMedica's future prospects.

Industry Context

Form 4 filings are standard practice for reporting changes in beneficial ownership by insiders, providing transparency to the market.

Stakeholder Impact

• The increased stake by Sanderling Venture Partners could positively influence shareholder confidence.

Key Dates